We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Requires Divestiture In $12.8B Acquisition

Law360 (October 17, 2006, 12:00 AM EDT) -- In a move to win regulatory approval for its proposed acquisition of a rival laboratory equipment maker, Thermo Electron Corp. has agreed to sell off Fisher Scientific International Inc.’s Genevac division, quelling the Federal Trade Commission’s opposition to the $12.8 billion deal.

The FTC had complained that the acquisition would stifle competition and innovation in the market for high-performance centrifugal vacuum evaporators. Thermo Electron and Fisher are the only two significant suppliers of centrifugal vacuum evaporators in the United States.

By divesting the Genevac division, Thermo...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.